Found 185 results in Expert Content

Summary: In this webinar, we explain why a lipid drug development platform can meet the need for speed to clinic and how the innovative lipid excipients and technologies could solve formulation challenges, optimizing bioavailability for early phase molecules, improve patient compliance and bring products faster to market.

Summary: Three early drug development experts present insights and techniques to help your clients get their molecules from preclinical to Phase 1 studies.

Summary: Phase-appropriate CMC-related activities can facilitate the transition from early development through commercialization.

Summary: Drug development requires integrating multi-disciplinary business, regulatory and scientific activities. To successfully support a client’s program, it is imperative to provide advice and services that support all three in the context of a program’s goal. In this exclusive webinar presented by Jim Spavins...

Summary: Integrated approach from development to clinical and benefits of working with a single integrated provider.

Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry.

The development of orally administered small molecules is more challenging as an many have poor aqueous solubility and bioavailability.

Summary: Characterize lead molecules and develop the best pathway to bring them to Phase I studies and beyond.

Summary: Thousands of drug candidates are abandoned annually due to solubility and bioavailability issues, but advanced formulation technologies can profoundly impact how a drug compound...

This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development.